CII
MRNA icon

Capital International Inc’s Moderna MRNA Stock Holding History

Capital International Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-9,694
Closed -$1M – 337
2023
Q3 		$1M Sell
9,694
-1,182
-11% -$132K 0.02% 277
2023
Q2 		$1.32M Sell
10,876
-4,137
-28% -$552K 0.02% 275
2023
Q1 		$2.31M Buy
15,013
+11,017
+276% +$1.82M 0.05% 215
2022
Q4 		$718K Buy
+3,996
New +$653K 0.02% 263
2022
Q1 		– Sell
-2,479
Closed -$630K – 305
2021
Q4 		$630K Buy
2,479
+146
+6% +$42.7K 0.01% 285
2021
Q3 		$898K Sell
2,333
-388
-14% -$143K 0.01% 278
2021
Q2 		$639K Sell
2,721
-10,011
-79% -$1.79M 0.01% 283
2021
Q1 		$1.67M Buy
+12,732
New +$1.84M 0.02% 263

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Inc's MRNA Position: Q4 2023 in Review

Capital International Inc sold out of Moderna (MRNA) in Q4 2023, closing a stake of 9,694 shares — an estimated $1M sold.

Capital International Inc first reported a position in MRNA in Q1 2021 and held it in 8 quarters. The position peaked at $2.31M in Q1 2023. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Capital International Inc reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Capital International Inc sold 9,694 Moderna shares in Q4 2023, an estimated $1M.
  • Capital International Inc first reported a position in Moderna in Q1 2021 and held it in 8 quarters.
  • Capital International Inc's Moderna position peaked at $2.31M in Q1 2023.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Capital International Inc's 13F filing for Q4 2023, filed 13 Feb 2024.